108 related articles for article (PubMed ID: 1509748)
21. Discordant results from "real-world" patient samples assayed for digoxin.
Jones TE; Morris RG
Ann Pharmacother; 2008 Dec; 42(12):1797-803. PubMed ID: 19033482
[TBL] [Abstract][Full Text] [Related]
22. Methods of theophylline assay and therapeutic monitoring of this drug.
Mounié J; Richard L; Ribon B; Hersant J; Sarmini H; Houin G
Ann Biol Clin (Paris); 1990; 48(5):287-93. PubMed ID: 2195925
[TBL] [Abstract][Full Text] [Related]
23. Comparability and imprecision of 8 frequently used commercially available immunoassays for therapeutic drug monitoring.
Shipkova M; Petrova DT; Rosler AE; Orth M; Engelmayer J; Wieland E; Brandhorst G; Oellerich M
Ther Drug Monit; 2014 Aug; 36(4):433-41. PubMed ID: 24646729
[TBL] [Abstract][Full Text] [Related]
24. Interlaboratory variability in drug assay: a comparison of quality control data with reanalysis of routine patient samples. II: Digoxin. Clinical Pharmacology and Toxicology Study Group, Italian Society for Clinical Biochemistry.
Ther Drug Monit; 1991 Mar; 13(2):140-5. PubMed ID: 2053121
[TBL] [Abstract][Full Text] [Related]
25. Cyclosporin whole blood immunoassays (AxSYM, CEDIA, and Emit): a critical overview of performance characteristics and comparison with HPLC.
Schütz E; Svinarov D; Shipkova M; Niedmann PD; Armstrong VW; Wieland E; Oellerich M
Clin Chem; 1998 Oct; 44(10):2158-64. PubMed ID: 9761250
[TBL] [Abstract][Full Text] [Related]
26. [Therapeutic drug monitoring in general practice--indications and interpretation].
Bode-Böger SM; Böger RH; Frölich JC
Z Arztl Fortbild (Jena); 1993 Mar; 87(3):201-10. PubMed ID: 8470405
[No Abstract] [Full Text] [Related]
27. Adaptation of EMIT drug assays to a random-access automated clinical analyzer.
Boyd JC; Savory MG; Margrey M; Herold DA; Shipe JR; Savory J
Ann Clin Lab Sci; 1985; 15(1):39-44. PubMed ID: 3882047
[TBL] [Abstract][Full Text] [Related]
28. Restricted-access media high pressure liquid chromatography vs fluorescence polarization immunoassay for analysis of carbamazepine in human plasma.
Ma J; Zhu PL; Xie JW; Jia ZP; Yang JS
Acta Pharmacol Sin; 2002 Jan; 23(1):87-91. PubMed ID: 11860744
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of analytical methods and workflow performance of the Architect ci8200 integrated serum/plasma analyzer system.
Hubl W; Zogbaum M; Boyd JC; Savory J; Schubert M; Meyer D; Demant T
Clin Chim Acta; 2005 Jul; 357(1):43-54. PubMed ID: 15963793
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of fluorescence polarization assays for measuring valproic acid, phenytoin, carbamazepine and phenobarbital in serum.
Steijns LS; Bouw J; van der Weide J
Ther Drug Monit; 2002 Jun; 24(3):432-5. PubMed ID: 12021637
[TBL] [Abstract][Full Text] [Related]
31. [Fluorescence polarization immunoassay and microparticle enzyme immunoassay].
Suguri M; Hirose N; Myoga A; Doss R; Tatsumi N
Rinsho Byori; 1996 Nov; 44(11):1072-5. PubMed ID: 8953938
[TBL] [Abstract][Full Text] [Related]
32. [Evaluation of Viva-E drug testing system].
Chung HS; Lee ST; Lee SY
Korean J Lab Med; 2007 Oct; 27(5):330-7. PubMed ID: 18094597
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of an enzyme immunochromatography method for carbamazepine: a comparison with enzyme-multiplied immunoassay technique, fluorescence polarization immunoassay, and high-performance liquid chromatography.
Oles KS; Penry JK; Dyer RD
Ther Drug Monit; 1989; 11(4):471-6. PubMed ID: 2662480
[TBL] [Abstract][Full Text] [Related]
34. Quantification of carbamazepine, carbamazepine-10,11-epoxide, phenytoin and phenobarbital in plasma samples by stir bar-sorptive extraction and liquid chromatography.
Queiroz RH; Bertucci C; Malfará WR; Dreossi SA; Chaves AR; Valério DA; Queiroz ME
J Pharm Biomed Anal; 2008 Sep; 48(2):428-34. PubMed ID: 18486397
[TBL] [Abstract][Full Text] [Related]
35. Preliminary observations on the Quality Assurance Service Therapeutic Drug Monitoring Program.
Lohff MR
Am J Clin Pathol; 1980 Oct; 74(4 Suppl):542-5. PubMed ID: 7435445
[TBL] [Abstract][Full Text] [Related]
36. Antiepileptic TDM pattern at a tertiary care hospital in India.
Jose VM; Medhi B; Pandhi P
Nepal Med Coll J; 2006 Jun; 8(2):107-10. PubMed ID: 17017400
[TBL] [Abstract][Full Text] [Related]
37. [Enzyme immunoassay of drug in blood (serum)].
Nishihara K
Nihon Rinsho; 1995 Sep; 53(9):2301-9. PubMed ID: 7474397
[TBL] [Abstract][Full Text] [Related]
38. CEDIA for screening drugs of abuse in urine and the effect of adulterants.
Wu AH; Forte E; Casella G; Sun K; Hemphill G; Foery R; Schanzenbach H
J Forensic Sci; 1995 Jul; 40(4):614-8. PubMed ID: 7595298
[TBL] [Abstract][Full Text] [Related]
39. Effect of heating sera under conditions necessary for deactivation of human immunodeficiency virus on commonly monitored therapeutic drugs.
Dasgupta A; Bard D
Ther Drug Monit; 1994 Dec; 16(6):612-5. PubMed ID: 7878703
[TBL] [Abstract][Full Text] [Related]
40. Effect of plantain on therapeutic drug monitoring of digoxin and thirteen other common drugs.
Dasgupta A; Davis B; Wells A
Ann Clin Biochem; 2006 May; 43(Pt 3):223-5. PubMed ID: 16704760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
